Literature DB >> 20922136

Asian society of gynecologic oncology workshop 2010.

Dong Hoon Suh1, Jae Weon Kim, Mohamad Farid Aziz, Uma K Devi, Hextan Y S Ngan, Joo-Hyun Nam, Seung Cheol Kim, Tomoyasu Kato, Hee Sug Ryu, Shingo Fujii, Yoon Soon Lee, Jong Hyeok Kim, Tae-Joong Kim, Young Tae Kim, Kung-Liahng Wang, Taek Sang Lee, Kimio Ushijima, Sang-Goo Shin, Yin Nin Chia, Sarikapan Wilailak, Sang Yoon Park, Hidetaka Katabuchi, Toshiharu Kamura, Soon-Beom Kang.   

Abstract

This workshop was held on July 31-August 1, 2010 and was organized to promote the academic environment and to enhance the communication among Asian countries prior to the 2nd biennial meeting of Australian Society of Gynaecologic Oncologists (ASGO), which will be held on November 3-5, 2011. We summarized the whole contents presented at the workshop. Regarding cervical cancer screening in Asia, particularly in low resource settings, and an update on human papillomavirus (HPV) vaccination was described for prevention and radical surgery overview, fertility sparing and less radical surgery, nerve sparing radical surgery and primary chemoradiotherapy in locally advanced cervical cancer, were discussed for management. As to surgical techniques, nerve sparing radical hysterectomy, optimal staging in early ovarian cancer, laparoscopic radical hysterectomy, one-port surgery and robotic surgery were introduced. After three topics of endometrial cancer, laparoscopic surgery versus open surgery, role of lymphadenectomy and fertility sparing treatment, there was a special additional time for clinical trials in Asia. Finally, chemotherapy including neo-adjuvant chemotherapy, optimal surgical management, and the basis of targeted therapy in ovarian cancer were presented.

Entities:  

Keywords:  ASGO; Cervical caner; Clinical trials; Endometrial cancer; Ovarian cancer; Workshop

Year:  2010        PMID: 20922136      PMCID: PMC2948221          DOI: 10.3802/jgo.2010.21.3.137

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  80 in total

1.  Radical abdominal trachelectomy and pelvic lymphadenectomy with uterine conservation and subsequent pregnancy in the treatment of early invasive cervical cancer.

Authors:  Daniel Dargent
Journal:  Am J Obstet Gynecol       Date:  2002-12       Impact factor: 8.661

2.  Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy.

Authors:  Shingo Fujii; Kenji Takakura; Noriomi Matsumura; Toshihiro Higuchi; Shigeo Yura; Masaki Mandai; Tsukasa Baba; Shinya Yoshioka
Journal:  Gynecol Oncol       Date:  2007-10       Impact factor: 5.482

3.  Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a meta-analysis.

Authors:  Woong Ju; Seung-Kwon Myung; Yeol Kim; Hyuck Jae Choi; Seung Cheol Kim
Journal:  Int J Gynecol Cancer       Date:  2009-04       Impact factor: 3.437

4.  Effect of nerve-sparing radical hysterectomy on bladder function recovery and quality of life in patients with cervical carcinoma.

Authors:  Jiahan Wu; Xishi Liu; Keqin Hua; Changdong Hu; Xiaojun Chen; Xin Lu
Journal:  Int J Gynecol Cancer       Date:  2010-07       Impact factor: 3.437

5.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

6.  Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer.

Authors:  Takao Hidaka; Akitoshi Nakashima; Tomoko Shima; Toru Hasegawa; Shigeru Saito
Journal:  Obstet Gynecol Int       Date:  2010-02-04

7.  Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.

Authors:  Rumi Sasaki; Mako Narisawa-Saito; Takashi Yugawa; Masatoshi Fujita; Hironori Tashiro; Hidetaka Katabuchi; Tohru Kiyono
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

8.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

9.  Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer.

Authors:  Alessandro Santi; Annette Kuhn; Thomas Gyr; Markus Eberhard; Silke Johann; Andreas R Günthert; Michael D Mueller
Journal:  Surg Endosc       Date:  2009-06-16       Impact factor: 4.584

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  6 in total

1.  Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients.

Authors:  Chel Hun Choi; Joon-Yong Chung; Ho-Seop Park; Minsik Jun; Yoo-Young Lee; Byung-Gie Kim; Stephen M Hewitt
Journal:  Hum Pathol       Date:  2015-03-11       Impact factor: 3.466

2.  Prognostic significance of positive lymph node number in early cervical cancer.

Authors:  Jung-Woo Park; Jong Woon Bae
Journal:  Mol Clin Oncol       Date:  2016-03-30

3.  Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.

Authors:  Chel Hun Choi; Joon-Yong Chung; Eun Joo Chung; John D Sears; Jeong-Won Lee; Duk-Soo Bae; Stephen M Hewitt
Journal:  BMC Cancer       Date:  2016-07-11       Impact factor: 4.430

4.  Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.

Authors:  Chel Hun Choi; Joon-Yong Chung; Jae-Hoon Kim; Byoung-Gie Kim; Stephen M Hewitt
Journal:  J Transl Med       Date:  2016-05-06       Impact factor: 5.531

Review 5.  The Role of Galectins in Cervical Cancer Biology and Progression.

Authors:  Lufang Wang; Yanyan Zhao; Yanshi Wang; Xin Wu
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

6.  The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer.

Authors:  Fengying Xu; Fengying Zhang; Qian Wang; Ying Xu; Shuifang Xu; Caihong Zhang; Lihua Wang
Journal:  BMC Immunol       Date:  2021-09-03       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.